Zanubrutinib monotherapy for patients with relapsed or refractory non-germinal center diffuse large B-cell lymphoma: results from a phase 2, single-arm, multicenter, study

 ABSTRACT   06/2020

For more information about this publication, please submit a medical information request.

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!